Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research

Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with XOMA Corporation, setting the stage for a ... Read More